Compare Baroda BNP Paribas Health and Wellness Fund vs SBI Healthcare Opportunities Fund
Baroda BNP Paribas Health and Wellness Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.7
1.99
NAV
₹10.40
₹565.02
Fund Started
09 Jun 2025
04 Jun 1999
Fund Size
₹487.35 Cr
₹5870.00 Cr
Exit Load
Exit Load for units in excess of 10% of the investment,1% will be charged for redemption within 1 year.
Exit load of 0.50% if redeemed within 15 days
1 Year
4.96%
12.47%
3 Year
-
20.35%
5 Year
-
15.74%
Equity
97.06%
95.53%
Cash
0.16%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 8.58% |
Torrent Pharmaceuticals Ltd. | 7.88% |
Divi's Laboratories Ltd. | 7.82% |
Ipca Laboratories Ltd. | 6.13% |
Laurus Labs Ltd. | 6.09% |
Lupin Ltd. | 5.79% |
Apollo Hospitals Enterprise Ltd. | 5.28% |
Fortis Healthcare Ltd. | 3.98% |
Dr. Lal Pathlabs Ltd. | 3.47% |
Mankind Pharma Ltd. | 3.34% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
09 Jun 2025
04 Jun 1999
